| Authors: |
Eke I; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC)., Zscheppang K; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC)., Dickreuter E; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC)., Hickmann L; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC)., Mazzeo E; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC)., Unger K; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC)., Krause M; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC)., Cordes N; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC). nils.cordes@oncoray.de. |
